probenecid has been researched along with Cerebral Infarction, Middle Cerebral Artery in 3 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freitas-Andrade, M | 1 |
| Bechberger, JF | 1 |
| MacVicar, BA | 1 |
| Viau, V | 1 |
| Naus, CC | 1 |
| Xiong, XX | 1 |
| Gu, LJ | 1 |
| Shen, J | 1 |
| Kang, XH | 1 |
| Zheng, YY | 1 |
| Yue, SB | 1 |
| Zhu, SM | 1 |
| Sas, K | 1 |
| Robotka, H | 1 |
| Rózsa, E | 1 |
| Agoston, M | 1 |
| Szénási, G | 1 |
| Gigler, G | 1 |
| Marosi, M | 1 |
| Kis, Z | 1 |
| Farkas, T | 1 |
| Vécsei, L | 1 |
| Toldi, J | 1 |
3 other studies available for probenecid and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Pannexin1 knockout and blockade reduces ischemic stroke injury in female, but not in male mice.
Topics: Adjuvants, Pharmaceutic; Animals; Connexins; Disease Models, Animal; Female; Humans; Infarction, Mid | 2017 |
Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice.
Topics: Animals; Aquaporin 4; Astrocytes; Brain Edema; Brain Injuries; Cerebral Infarction; Down-Regulation; | 2014 |
Kynurenine diminishes the ischemia-induced histological and electrophysiological deficits in the rat hippocampus.
Topics: Adjuvants, Pharmaceutic; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Elec | 2008 |